Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelines.
about
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention.Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention.Switching P2Y12-receptor inhibitors in patients with coronary artery disease.A Safety Evaluation of Cangrelor in Patients Undergoing PCI.Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patients.Optimizing the Use of Cangrelor in the Real World.Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.Antithrombotic therapy for patients with STEMI undergoing primary PCI.Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".
P2860
Q38378830-B98FF823-8F22-4014-BA9D-4E49F75EC878Q38401281-37A5D160-2F7D-4FF3-A5D6-7DF80D1F886AQ38568711-464DCF0A-09AA-46F1-B5B2-5A54DB427E6EQ38672923-415A8A69-ECBD-4384-9EA6-2783F09059C0Q38682012-F2A5419B-D8BF-4CC8-AE5E-C7CE6A89B652Q38765117-E550406E-4411-4789-BC39-8DB0DF6D3467Q38817125-767ABB54-D368-4164-B41E-7A05A7AA9775Q38974706-25D9AE95-8C88-4861-8A17-2BF28E6C5EC9Q39147735-7FB0ABE2-7575-4FE3-ADA2-E75D48DAF30CQ47705387-B44532B7-9BE6-4F92-8870-E114E447671AQ47707224-020FFEC4-2D3E-424E-932B-4BEBE4820A84Q50864337-3FC1D106-3BBF-4EFF-BFF1-C2C441D338AB
P2860
Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pretreatment with antiplatelet ...... dence and practice guidelines.
@en
type
label
Pretreatment with antiplatelet ...... dence and practice guidelines.
@en
prefLabel
Pretreatment with antiplatelet ...... dence and practice guidelines.
@en
P1476
Pretreatment with antiplatelet ...... dence and practice guidelines.
@en
P2093
Dominick J Angiolillo
P304
P356
10.1161/CIRCINTERVENTIONS.114.002301
P577
2015-03-01T00:00:00Z